Managed Healthcare Executive March 1, 2021
Peter Wehrwein

The value-based model hasn’t produced cost savings and is not likely “to make the cut” to become permanent, says Kavita Patel, a former top healthcare official in the Obama administration.

The Oncology Care Model has had no effect on costs and is not likely “to make the cut” to become permanent in the new administration, said Kavita Patel.

Finding ways to expand Medicaid and solving the “Goldilocks” problem of identifying the just-right level of telehealth will be among the healthcare problems the Biden administration will tackle, according to Kavita Patel.

But for the community oncologists listening to her remarks today, Patel’s damning assessment of the Oncology Care Model (OCM) may be the most salient part of her...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Payment Models, Physician, Provider, Value Based
The Task Force Releases Advancing Health Equity within Value-Based Care
The Role Of Medicaid Accountable Care Organizations In Maternal Health
Report: More Employers Are Looking To Deploy Value-Based Care
Opinion: The world is relying on the United States to get value-based drug pricing right
The world is relying on the United States to get value-based drug pricing right

Share This Article